These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37142613)

  • 1. Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions.
    Shin HI; Bang JI; Kim GJ; Kim MR; Sun DI; Kim SY
    Sci Rep; 2023 May; 13(1):7257. PubMed ID: 37142613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS).
    Ko JY; Kim MJ; Lee SG; Kho HS
    Arch Gerontol Geriatr; 2012; 55(3):755-61. PubMed ID: 22040716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic changes of saliva and taste in burning mouth syndrome patients.
    Imura H; Shimada M; Yamazaki Y; Sugimoto K
    J Oral Pathol Med; 2016 Mar; 45(3):231-6. PubMed ID: 26293497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.
    Zborowski J; Konopka T
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome.
    Arduino PG; Cafaro A; Garrone M; Gambino A; Cabras M; Romagnoli E; Broccoletti R
    Lasers Med Sci; 2016 May; 31(4):811-6. PubMed ID: 26873501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.
    Mitsikostas DD; Ljubisavljevic S; Deligianni CI
    J Headache Pain; 2017 Dec; 18(1):40. PubMed ID: 28357703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of salivary function in patients with burning mouth syndrome.
    Lee YC; Hong IK; Na SY; Eun YG
    Oral Dis; 2015 Apr; 21(3):308-13. PubMed ID: 24962264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
    Danhauer SC; Miller CS; Rhodus NL; Carlson CR
    J Orofac Pain; 2002; 16(4):305-11. PubMed ID: 12455431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burning mouth syndrome: a review and update.
    Sun A; Wu KM; Wang YP; Lin HP; Chen HM; Chiang CP
    J Oral Pathol Med; 2013 Oct; 42(9):649-55. PubMed ID: 23772971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose naltrexone for treatment of burning mouth syndrome.
    Sangalli L; Miller CS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Apr; 135(4):e83-e88. PubMed ID: 35851249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes and related clinical characteristics in patients with burning mouth syndrome.
    Kim MJ; Kim J; Kho HS
    Oral Dis; 2021 Sep; 27(6):1507-1518. PubMed ID: 33098162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical clonazepam for burning mouth syndrome: Is it efficacious in patients with anxiety or depression?
    Rossella I; Alessandro V; Naman R; Gary K; Hervé SY
    J Oral Rehabil; 2022 Jan; 49(1):54-61. PubMed ID: 34716948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial.
    Grémeau-Richard C; Dubray C; Aublet-Cuvelier B; Ughetto S; Woda A
    Pain; 2010 Apr; 149(1):27-32. PubMed ID: 20083352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report.
    Watanabe M; Takao C; Maeda C; Nayanar G; Tominaga R; Kimura Y; Tu TTH; Nagamine T; Toyofuku A
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):464-467. PubMed ID: 38500267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burning mouth syndrome: a systematic review of treatments.
    Liu YF; Kim Y; Yoo T; Han P; Inman JC
    Oral Dis; 2018 Apr; 24(3):325-334. PubMed ID: 28247977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of burning mouth syndrome.
    Salerno C; Di Stasio D; Petruzzi M; Lauritano D; Gentile E; Guida A; Maio C; Tammaro M; Serpico R; Lucchese A
    Front Biosci (Elite Ed); 2016 Jan; 8(1):213-8. PubMed ID: 26709657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burning mouth syndrome: a review of etiology, diagnosis, and management.
    Teruel A; Patel S
    Gen Dent; 2019; 67(2):24-29. PubMed ID: 30875303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome.
    Treldal C; Jacobsen CB; Mogensen S; Rasmussen M; Jacobsen J; Petersen J; Lynge Pedersen AM; Andersen O
    Oral Dis; 2016 Mar; 22(2):123-31. PubMed ID: 26575180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.